Progress in the Research and Targeted Therapy of ErbB/HER Receptors in Urothelial Bladder Cancer

Bladder cancer is a lethal malignancy and a majority of bladder cancer arise from urothelial cells. Infiltration and metastasis are barriers for the radical cystectomy to achieve favored outcome and are the main cause of death. Systemic therapy, including chemotherapy, targeted therapy, and immunoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dong, Ye, Yunlin, Guo, Shengjie, Yao, Kao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735837/
https://www.ncbi.nlm.nih.gov/pubmed/35004854
http://dx.doi.org/10.3389/fmolb.2021.800945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735837/
https://www.ncbi.nlm.nih.gov/pubmed/35004854
http://dx.doi.org/10.3389/fmolb.2021.800945

Ejemplares similares